XML 15 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating Activities    
Net income (Loss) $ 42 $ 999
Adjustments to reconcile to net cash provided by (used in) operating activities:    
Depreciation and amortization 691 714
Goodwill and other asset impairment charges 113 671
Deferred taxes (387) 170
Credits associated with last-in, first-out inventory method (114) (64)
Equity earnings and charges from investment in Change Healthcare Joint Venture 1,478 162
Non-cash operating lease expense 276  
Other non-cash items 542 (95)
Changes in assets and liabilities, net of acquisitions:    
Receivables (1,044) (1,543)
Inventories (689) (756)
Drafts and accounts payable (929) 175
Taxes 11 (131)
Operating lease liabilities (287)  
Other 17 (161)
Net cash provided by (used in) operating activities (280) 141
Investing Activities    
Payments for property, plant and equipment (242) (309)
Capitalized software expenditures (96) (96)
Acquisitions, net of cash, cash equivalents and restricted cash acquired (97) (866)
Other 26 120
Net cash used in investing activities (409) (1,151)
Financing Activities    
Proceeds from short-term borrowings 15,852 30,392
Repayments of short-term borrowings (13,743) (29,346)
Proceeds from issuances of long-term debt 0 1,099
Common stock transactions:    
Issuances 89 46
Share repurchases, including shares surrendered for tax withholding (1,951) (1,388)
Dividends paid (222) (216)
Other (279) (270)
Net cash provided by (used in) financing activities (254) 317
Effect of exchange rate changes on cash, cash equivalents and restricted cash 27 (130)
Net decrease in cash, cash equivalents and restricted cash (916) (823)
Cash, cash equivalents and restricted cash at beginning of period 2,981 2,672
Cash, cash equivalents and restricted cash at end of period $ 2,065 $ 1,849